CHINA SHENGHUO PHARM HLD INC (KUN)
Other Resources for KUN
 |
|
|
| Commentary | | No Commentary Found for This Ticker. |
|
|
|
|
| Shenghuo Pharmaceutical Holdings, Inc. is a leading specialty pharmaceutical company that focuses on the research, development, production and marketing of Sanchi-based medicinal products. Through its subsidiary, Kunming Shenghuo Pharmaceutical Group Co., Ltd it owns thirty-one State Food and Drug Association approved medicines, including the flagship product Xuesaitong Soft Capsules, which has already been listed in the Insurance Catalogue. At present, Shenghuo incorporates a sales network of agencies and representatives throughout China, which markets Sanchi-based traditional Chinese medicine into one thousand six hundred fifty hospitals and one thousand five hundred drug stores as prescription and OTC drugs primarily for the treatment of cardiovascular, cerebrovascular and peptic ulcer disease. The Company also exports medicinal products to Asian countries such as Indonesia, Thailand and Kyrgyzstan. | | | | No brokerage coverage for KUN |
| |
|
|
| KUN Consensus Forecasts |
| |
|
|
|
What The Community Thinks
Total Players
4 Buy
2 Sell
|
- Blog Posts
-
No related Blog Posts.
- Commentary
-
- Picks
-
|
|
|
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment